You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

港股異動 | 賽生藥業復牌大升11% 獲Silver Pegasus溢價約17.21%提私有化

格隆匯 04-02 11:15
賽生藥業(6600.HK)復牌大升11%,高見17.92港元逼近歷史高價,市值111.5億港元。消息上,賽生藥業日前公佈,Silver Pegasus Investment建議以協議安排方式私有化及撤銷公司上市地位。每股作價18.8元,較停牌前收市價16.04元溢價約17.21%。此外,根據購股權激勵計劃,如悉數行使目標購股權會導致發行5,442.1萬股新股份,佔公司擴大後股本約7.98%。

20240502賽生藥業06600
Relevant Stocks